share_log

Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $77 Price Target

Moomoo 24/7 ·  Apr 23 12:55

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $77 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment